Product Description
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analog of α-MSH that acts primarily at melanocortin receptors MC3R and MC4R. Research models show it modulates central signaling pathways associated with pigmentation, appetite regulation, and autonomic response — distinct from peripherally-acting peptides. Initial development was for sunless tanning; later research focused on CNS-mediated endpoints.









